
Jennifer Larson
Contributor
Jennifer Larson is a freelance writer who lives in Nashville, Tennessee. She has a bachelor's degree from Rhodes College in Memphis, Tennessee, and a master's degree in journalism from the University of Maryland, College Park. She's a member of the Association of Healthcare Journalists and the Society of Professional Journalists. When she's not writing, Jennifer enjoys reading, running, dancing, watching baseball, and chauffeuring her two young sons to all their extracurricular activities.
Connect with Jennifer Larson
Sign up for health updates in your inbox
Articles

News
FDA approves generic Xarelto
There’s a new—hopefully, lower cost—option for people who take anticoagulants to manage heart disease
Mar. 7, 2025

News
FDA approves rapid-acting insulin biosimilar
Merilog works like NovoLog to help control blood sugar when injected five to ten minutes before meals
Feb. 21, 2025

Drug Info
Microdosing Ozempic
It’s the latest weight-loss trend, but is it safe?
Feb. 11, 2025

News
Ozempic for kidney disease
This diabetes medication is now indicated to prevent the worsening of kidney disease, kidney failure, and death due to cardiovascular disease
Jan. 31, 2025

News
FDA approves first generic once-daily GLP-1
Liraglutide, the generic of Victoza, is now available to treat Type 2 diabetes, alongside diet and exercise
Jan. 2, 2025

News
Zepbound for sleep apnea
It’s the first medication that reduces symptom severity, reducing breathing interruptions at night
Jan. 2, 2025

News
FDA issues warning to GLP-1 compounders
The U.S. Food and Drug Administration is sounding the alarm about the risks of taking unapproved versions of Ozempic, Wegovy, Zepbound, and Mounjaro
Dec. 19, 2024

Drug Info
Metoprolol for anxiety
This prescription reduces some of the physical symptoms of stress, like a racing heart
Dec. 13, 2024

Wellness
Pineapple and diabetes
This sweet fruit is healthy in moderation—especially when paired with a lean protein or fat
Oct. 14, 2024

Drug Info
Is MiraLAX safe daily?
It’s safe to take daily, but only for a limited time
Aug. 30, 2024

News
FDA approves epinephrine nasal spray
Neffy is the first needle-free epinephrine to treat life-threatening anaphylaxis
Aug. 12, 2024